TABLE 4.
Zoledronic Acid Interval Dosing | |||
---|---|---|---|
|
|||
Outcomes | Standard (n = 121)a | Extended (n = 35)a | P |
Patients with SRE, No. (%) | 37 (31) | 8 (23) | .374 |
| |||
Skeletal-related events | |||
Fracture | 22 (36) | 3 (20) | .172 |
Spinal compression | 9 (14) | 2 (13) | .726 |
Radiation | 26 (42) | 9 (60) | .598 |
Surgery | 5 (8) | 1 (7) | .723 |
| |||
Osteonecrosis of jaw | 3 (3) | 0 (0) | .347 |
Abbreviation: SRE, skeletal-related event.
Total number of patients in each group.